Katharina Schwarz

Katharina Schwarz

Auto-generated profile, based on publicly available information

Katharina Schwarz

Fraunhofer ITEM Hannover Germany

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2025 in Toxics
Verified
Journal Article
Open access
PDF file
NSNikaeta Sadekar
Nikaeta Sadekar
HBHolger Behrsing
Holger Behrsing
THTanja Hansen
Tanja Hansen
VPVivek Patel
Vivek Patel
HPHazel Paulo
Hazel Paulo
AAAnne Marie Api
Anne Marie Api
There is increased interest in developing non-animal test systems for inhalation exposure safety assessments. However, defined methodologies are absent for predicting local respiratory effects from inhalation exposure to irritants. The current study introduces a concept for applying in vitro and in silico methods for inhalation exposure safety assessment. Three in vitro systems, representing the upper (MucilAir™—nasal epithelial tissue) and lower (A549 cells and human precision-cut lung slices) human respiratory regions, were exposed to six respiratory irritants. These irritant exposures were conducted as liquid droplets, aerosol, or vapors, and samples were collected over 24 h. Cytotoxicity, cytokine release, epithelial resistance, oxidative stress, and mitochondrial membrane potential were measured. To determine the human relevance of in vitro exposures, airway surface depositions were predicted by simulating airborne concentrations equivalent to the Cramer class III inhalation threshold of toxicological concern limit of 0.47 mg/person/day using an in silico model. A > 100-fold margin of exposure was calculated comparing lowest concentrations showing in vitro effects to in silico simulated values. While further studies are needed, this manuscript presents a basic requirement for employing non-animal methods to inform inhalation exposure safety assessments by combining in vitro and in silico assays.

4 October 2025 in CPT: Pharmacometrics & Systems Pharmacology
Verified
Journal Article
Open access
NNNorman Nowak
Norman Nowak
SESylvia E. Escher
Sylvia E. Escher
KSKatharina Schwarz
Katharina Schwarz
Assessing the risk or benefit of an inhaled substance is challenging due to the variety of forms it can take (gas, vapor, particle, or droplet) and the complex biological processes involved in its uptake and retention. Physiologically based kinetic (PBK) models offer an alternative to in vivo experiments. However, PBK models for inhalational uptake are to date either designed for gases/vapors or airborne particulates, often with only low regional compartmentalization. The here‐presented, newly developed model combines both applications. Its mechanisms are an amalgamation of PBK and non‐PBK models integrated into a multicompartmental description of the human lung to include the relevant uptake and clearance processes in the different lung regions, of which macrophage‐mediated dissolution is novel to PBK modeling. The model was designed to use a minimal number of substance‐specific input parameters, which can be derived from in vitro assays or in silico methods. Model predictions for hypothetical substances with varying physicochemical properties were performed, along with rudimentary sensitivity analyses to identify the most important parameters for gases/vapors and particles. This novel PBK model combines all these aspects and provides in silico predictions of systemic and local lung concentrations, reducing uncertainty in risk assessments and supporting drug development. It serves as a valuable tool to translate nominal ambient air doses into effective localized doses within the lung.

26 June 2023 in Annals of Work Exposures and Health
Verified
Journal Article
Open access
PDF file
KSKatharina Schwarz
Katharina Schwarz
KBKatharina Blümlein
Katharina Blümlein
Thomas GöenThomas Göen
Thomas Göen
SHStefan Hahn
Stefan Hahn
RHRalph Hebisch
Ralph Hebisch
MKMonika Krug
Monika Krug
The application of biocidal products by foam is considered an alternative to droplet spraying when disinfecting surfaces or fighting infestations. Inhalation exposure to aerosols containing the biocidal substances cannot be ruled out during foaming. In contrast to droplet spraying, very little is known about aerosol source strength during foaming. In this study, the formation of inhalable aerosols was quantified according to the aerosol release fractions of the active substance. The aerosol release fraction is defined as the mass of active substance transferred into inhalable airborne particles during foaming, normalised to the total amount of active substance released through the foam nozzle. Aerosol release fractions were measured in control chamber experiments where common foaming technologies were operated according to their typical conditions of use. These investigations include foams generated mechanically by actively mixing air with a foaming liquid as well as systems that use a blowing agent for foam formation. The values of the aerosol release fraction ranged from 3.4 × 10−6 to 5.7 × 10−3 (average values). For foaming processes based on mixing air and the foaming liquid, the release fractions could be correlated to the process and foam parameters such as foam exit velocity, nozzle dimensions, and foam expansion ratio.

1 May 2023
Verified
Conference Paper
Closed access
HOH. Obernolte
H. Obernolte
CHC. Hesse
C. Hesse
DWD. Winterberg
D. Winterberg
GPG. Pohlmann
G. Pohlmann
ABA. Braun
A. Braun
KSK. Schwarz
K. Schwarz

1 May 2023
Verified
Conference Paper
Closed access
HOH. Obernolte
H. Obernolte
KSK. Schwarz
K. Schwarz
SCS. Cleeves
S. Cleeves
VBV. Beneke
V. Beneke
ACA. Vaslin Chessex
A. Vaslin Chessex
CPC. Pasquali
C. Pasquali